Mizuno, K.; Imai, N.; Yamamoto, T.; Yokoyama, S.; Yamamoto, K.; Ito, T.; Ishizu, Y.; Honda, T.; Kuzuya, T.; Ishigami, M.;
et al. Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma. Cancers 2023, 15, 2853.
https://doi.org/10.3390/cancers15102853
AMA Style
Mizuno K, Imai N, Yamamoto T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kuzuya T, Ishigami M,
et al. Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma. Cancers. 2023; 15(10):2853.
https://doi.org/10.3390/cancers15102853
Chicago/Turabian Style
Mizuno, Kazuyuki, Norihiro Imai, Takafumi Yamamoto, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Teiji Kuzuya, Masatoshi Ishigami,
and et al. 2023. "Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma" Cancers 15, no. 10: 2853.
https://doi.org/10.3390/cancers15102853
APA Style
Mizuno, K., Imai, N., Yamamoto, T., Yokoyama, S., Yamamoto, K., Ito, T., Ishizu, Y., Honda, T., Kuzuya, T., Ishigami, M., & Kawashima, H.
(2023). Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma. Cancers, 15(10), 2853.
https://doi.org/10.3390/cancers15102853
